Economic Evaluation of Three BRAF + MEK Inhibitors for the Treatment of Advanced Unresectable Melanoma With BRAF Mutation From a US Payer Perspective.

Details

Language :

English

ISSN :

10600280

Volume :

57

Issue :

9

Database :

Supplemental Index

Journal :

Annals of Pharmacotherapy

Publication Type :

Academic Journal

Accession number :

169855039

Full Text :

https://doi.org/10.1177/10600280221146878